---
title: "American Shared Hospital Services reports Q1 revenue $7.1M; adjusted EBITDA $1.12M, gross margin 18.2%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286442329.md"
description: "American Shared Hospital Services reported Q1 2026 revenue of $7.1 million, a 15.9% increase from Q1 2025. Adjusted EBITDA was $1.12 million, with a gross margin of 18.2%. The company recorded a net loss of $0.612 million, or $0.09 per diluted share. Growth was driven by a 30.2% increase in direct patient services revenue and higher procedure volumes. Management is focused on optimizing network utilization and improving reimbursement profiles while discussing potential debt extensions for growth."
datetime: "2026-05-14T15:53:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286442329.md)
  - [en](https://longbridge.com/en/news/286442329.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286442329.md)
---

# American Shared Hospital Services reports Q1 revenue $7.1M; adjusted EBITDA $1.12M, gross margin 18.2%

American Shared Hospital Services reported first-quarter 2026 results with revenue of $7.1 million and adjusted EBITDA of $1.124 million, reflecting year-over-year improvement in operating performance. Gross margin rose to $1.288 million (18.2%) while the company recorded a net loss attributable to the company of $0.612 million, or $0.09 per diluted share. Management said direct patient services expansion and higher procedure volumes drove results and that volumes are trending higher into Q2.

**Financial Highlights**

-   Total revenue: $7,084,000 for the three months ended March 31, 2026 (15.9% increase vs. $6,112,000 in Q1 2025).
-   Gross profit: $1,288,000, representing a gross margin of 18.2% (compared with $942,000, or 15.4%, in Q1 2025).
-   Operating loss: $(924,000) for the quarter, improved from $(1,299,000) in the prior-year period.
-   Net loss attributable to American Shared Hospital Services: $(612,000), or $(0.09) per diluted share (Q1 2025: $(625,000), $(0.10) per diluted share).
-   Adjusted EBITDA: $1,124,000 for Q1 2026, up from $949,000 in Q1 2025.

**Business Highlights**

-   Direct patient services expansion drove revenue growth, with direct patient services revenue increasing 30.2% year-over-year to approximately $4.1 million.
-   Increased procedure volumes across treatment centers: Gamma Knife procedures rose 10.1% (229 procedures) and proton beam radiation therapy (PBRT) treatments increased 20.7% to 1,003.
-   Rhode Island centers and the Puebla, Mexico facility continued to ramp utilization and contributed materially to segment growth.
-   Leasing revenue remained stable at approximately $3.0 million, with impacts from prior Gamma Knife agreement expirations partially offset by improved volumes at upgraded sites.
-   Management continues operational focus on optimizing existing network utilization, improving reimbursement profiles, and progressing discussions with lenders on potential debt extensions to support growth.

Original SEC Filing: AMERICAN SHARED HOSPITAL SERVICES \[ AMS \] - 8-K - May. 14, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [AMS.US](https://longbridge.com/en/quote/AMS.US.md)

## Related News & Research

- [American Shared Hospital Services Receives Notice Of Events Of Default Under Credit Agreement](https://longbridge.com/en/news/288769980.md)
- [CECO Environmental updates 2026 outlook after Thermon acquisition, sees $40M+ synergies](https://longbridge.com/en/news/289230300.md)
- [Axon Enterprise Touts AI, Global Markets and Counter-Drone Demand as Growth Engines](https://longbridge.com/en/news/288918401.md)
- [18:45 ETDriven Tech Named to CRN Solution Provider 500 List for 2026](https://longbridge.com/en/news/289245372.md)
- [Elastic N.V. FY 2026: Revenue $1.74B, EPS $3.43— 10-K Summary](https://longbridge.com/en/news/289105608.md)